To assess the effects of cancer‐induced iron deficiency on skeletal muscle metabolism, we analyzed the transcript levels of the main cellular iron importer, transferrin receptor 1 (TFR1) in a cohort of cancer patients presenting body weight loss and anemia (Fig 1A and B). Here, TFRC is linked to anemia (phenotype).